NCT00905879View on ClinicalTrials.gov

Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2009

Study Completion Date

January 31, 2011

Conditions
Magnetic Resonance Imaging
Interventions
DRUG

Gadobutrol (Gadovist, BAY86-4875)

Patients who will need to undergo contrast enhanced MRI with gadobutrol (Gadovist)

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY